| Nov 10 |
ANI Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Nov 9 |
ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
| Nov 9 |
ANI Pharmaceuticals, Inc. (ANIP) Q3 2024 Earnings Call Transcript
|
| Nov 8 |
Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics
|
| Nov 8 |
ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass Estimates
|
| Nov 8 |
ANI: Q3 Earnings Snapshot
|
| Nov 8 |
ANI Pharmaceuticals Non-GAAP EPS of $1.34 beats by $0.25, revenue of $148.33M beats by $3.96M
|
| Nov 8 |
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
|
| Nov 7 |
ANI Pharmaceuticals Q3 2024 Earnings Preview
|
| Nov 4 |
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November
|
